- Review
Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma
- Wendy M. Covert and
- Jane E. Rogers
Advanced gastric adenocarcinoma (GAC) carries a poor prognosis. Targeted therapy in GAC has traditionally been limited to anti-human epidermal growth factor receptor-2 and anti-vascular endothelial growth factor agents. Recent years have brought immu...

